126 related articles for article (PubMed ID: 8572462)
1. [Professional practice in stage I melanoma. A national survey of dermatologists].
Poisson-Salomon AS; Mlika-Cabanne N; Cosquer M; Durieux P; Saiag P
Ann Dermatol Venereol; 1995; 122(5):259-62. PubMed ID: 8572462
[No Abstract] [Full Text] [Related]
2. [Modalities of follow-up after excision of stage I melanoma: practice survey in hospitals].
Couilliet D; Poisson-Salomon AS; Cosquer M; Guillaume JC
Ann Dermatol Venereol; 1995; 122(5):263-6. PubMed ID: 8572463
[No Abstract] [Full Text] [Related]
3. [Impact of French consensus conference concerning the follow-up of patients surgically treated for stage I melanoma among French dermatologists and oncologists].
Bafounta ML; Beauchet A; Poisson-Salomon AS; Saiag P
Ann Dermatol Venereol; 1999 Nov; 126(11):795-800. PubMed ID: 10612855
[TBL] [Abstract][Full Text] [Related]
4. [Malignant melanoma. Quality Assurance Committee of the German Society of Dermatology and the Professional Organization of German Dermatologists e. V].
Kaufmann R; Tilgen W; Garbe C
Hautarzt; 1998 Oct; 48 Suppl 1():S30-8. PubMed ID: 9866046
[No Abstract] [Full Text] [Related]
5. [Are there special therapeutic methods recommended by some physicians for the management of stage I melanoma?].
Revuz J
Ann Dermatol Venereol; 1995; 122(5):319-20. PubMed ID: 8572474
[No Abstract] [Full Text] [Related]
6. [Implication of French general practitioners in the follow-up of patients surgically treated for stage I melanoma].
Bafounta ML; Beauchet A; Poisson-Salomon AS; Saiag P
Ann Dermatol Venereol; 1999 Nov; 126(11):801-3. PubMed ID: 10612856
[TBL] [Abstract][Full Text] [Related]
7. [What are expected improvements in the follow-up and treatment of stage I melanoma?].
Thomas L
Ann Dermatol Venereol; 1995; 122(5):378-88. PubMed ID: 8572482
[No Abstract] [Full Text] [Related]
8. [After excision of primary stage I cutaneous melanoma, is an initial evaluation necessary?].
Richard-Lallemand MA
Ann Dermatol Venereol; 1995; 122(5):349-59. PubMed ID: 8572478
[No Abstract] [Full Text] [Related]
9. [New aspects of immunotherapy of malignant melanoma].
Enk A
Praxis (Bern 1994); 2001 Mar; 90(10):403-6. PubMed ID: 11305186
[TBL] [Abstract][Full Text] [Related]
10. [Inpatient and outpatient follow-up of grade I malignant melanoma].
Cordel N; Safa G; Balguerie X; De Preville P; Modeste A; Courville P; Boivin C; Pellerin A; Ziade J; Thiberville G; Laaengh-Michel N; Neveu C; Young P; Lauret P; Joly P
Ann Dermatol Venereol; 2000; 127(6-7):579-83. PubMed ID: 10930854
[TBL] [Abstract][Full Text] [Related]
11. Massive nodular melanoma: a case report.
Harting M; Tarrant W; Kovitz CA; Rosen T; Harting MT; Souchon E
Dermatol Online J; 2007 May; 13(2):7. PubMed ID: 17498426
[TBL] [Abstract][Full Text] [Related]
12. [Consensus conference. Follow-up of patients surgically treated for stage I melanoma. Paris, France, 30 March 1995].
Ann Dermatol Venereol; 1995; 122(5):250-391. PubMed ID: 8572460
[No Abstract] [Full Text] [Related]
13. [Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an M0 cutaneous melanoma, full report. National Federation of Cancer Campaign Centers. French Dermatology Society. Update of the 1995 Consensus Conference and the 1998 Standards, Options, and Recommendations].
Négrier S; Saiag P; Guillot B; Verola O; Avril MF; Bailly C; Cupissol D; Dalac S; Danino A; Dreno B; Grob JJ; Leccia MT; Renaud-Vilmer C; Bosquet L; ;
Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 2):10S3-10S85. PubMed ID: 16521904
[No Abstract] [Full Text] [Related]
14. [Prognostic evaluation of malignant melanoma].
Schmoeckel C; Bockelbrink A; Bockelbrink H; Braun-Falco O
Med Klin Prax; 1982 Sep; 77(19):50-1. PubMed ID: 7132900
[No Abstract] [Full Text] [Related]
15. [Melanoma malignancy].
Tilgen W
Hautarzt; 2008 Jun; 59(6):467-8. PubMed ID: 18463839
[No Abstract] [Full Text] [Related]
16. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France.
Grange F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A
Arch Dermatol; 2008 May; 144(5):629-36. PubMed ID: 18490589
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and treatment of malignant melanoma of the skin (a lecture)].
Denisov LE; Kurdina MI
Khirurgiia (Mosk); 1996; (1):17-22. PubMed ID: 8683912
[TBL] [Abstract][Full Text] [Related]
18. [Malignant melanoma. Prognostic factors].
Schnyder UW
Schweiz Rundsch Med Prax; 1988 Apr; 77(17):453-5. PubMed ID: 3375670
[No Abstract] [Full Text] [Related]
19. Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patients.
Gimotty PA; Guerry D; Flaherty K
J Clin Oncol; 2008 Feb; 26(4):517-8. PubMed ID: 18235111
[No Abstract] [Full Text] [Related]
20. [Question of the month. Should treatment of Dubreuilh's melanoma be carcinologic?].
Ann Dermatol Venereol; 1993; 120(6-7):506-8. PubMed ID: 8279802
[No Abstract] [Full Text] [Related]
[Next] [New Search]
